Proposing a Model for the National Hemovigilance Information System in Iran
-
Published:2020-04
Issue:2
Volume:13
Page:211-218
-
ISSN:1844-122X
-
Container-title:Journal of Medicine and Life
-
language:en
-
Short-container-title:JMedLife
Author:
Asadi Farkhondeh, , ,Ramezanghorbani Nahid,
Abstract
The present study aimed to propose a model for the national hemovigilance information system with a database approach, considering the importance and necessity of developing an information system for such a network.
This is an applied, descriptive, and cross-sectional study, which was conducted in 2018. The research population comprised hemovigilance information systems in advanced countries, including the USA, UK, Australia, and France. Data were collected from library sources and the Internet from 2000 to 2018. The proposed model for the national hemovigilance information system was introduced using comparative tables and based on the similarities and differences of systems in the studied countries. The proposed model was then validated using the two-step Delphi technique through a researcher-made questionnaire whose validity was confirmed, and reliability was approved by a Cronbach’s alpha of 94%.
The final model of the national hemovigilance information system comprised five main components: goals, organizations involved in the blood transfusion process, databases of blood transfusion organizations, data transfer flow between the databases of blood transfusion organizations, and transferable datasets, and hemovigilance-related committees. This model was approved by experts with an >85% agreement coefficient.
The national hemovigilance information system with a database approach can improve blood transfusion health by providing access to reliable sources on blood transfusion complications to everyone, especially the medical community. Thus, it is essential to implement this standard accurately and precisely control the practical methods of this process based on international guidelines.
Publisher
S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L
Reference25 articles.
1. 1. Delaney, M., Wendel, S., Bercovitz, R. S., Cid, J., Cohn, C., Dunbar, N. M., Apelseth, T. O., Popovsky, M., Stanworth, S. J., Tinmouth, A., Van De Watering, L., Waters, J. H., Yazer, M., and Ziman, A. (2016). Transfusion reactions: prevention, diagnosis, and treatment. Lancet, 388(10061), 2825-2836. 2. 2. Hosseini, E.A., Ghasabeh, Sh., and Ghasemzadeh, M. (2017). Leukocytes and transfusion related adverse events: the effects of leukoreduction process in the prevention of adverse reactions resulted from the transfusion of blood components: review article. Tehran University Medical Journal, 75(2), 77-84. 3. 3. De Vries, R. R., Faber, J.C., and Strengers, P.F. (2011). Haemovigilance: an effective tool for improving transfusion practice. Vox Sang, 100(1), 67-70. 4. 4. Mattisson, L., Lapidus, L. J., and Enocson, A. (2018). What is the influence of a delay to surgery, 24 hours on the rate of red blood cell transfusion in elderly patients with intertrochanteric or subtrochanteric hip fractures treated with cephalomedullary nails? Journal of orthopaedic trauma, 32(8), 403-407. 5. 5. Mukherjee, S., and R. Maiti (). Haemovigilance: A Current Update in Indian Perspective.” Journal of Clinical and Diagnostic Research : JCDR 10(11): EE05-EE09.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|